Zorka Milovanovic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Zorka Milovanovic has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Boban Stanojevic
University of Belgrade
1 shared publication - Bogomir Dimitrijevic
Laboratory for Radiobiology and Molecular Genetics “Vinca”, Institute of Nuclear Sciences, University of Belgrade, Mike Petrovica Alasa12-14, P.O. Box 522, 11000, Belgrade, Serbia
1 shared publication - Bozidar Rulic
Institute of Oncology and Radiology of Serbia, Surgical Oncology Clinic, Pasterova 14, 11000, Belgrade, Serbia
1 shared publication - Lidija Todorović
Laboratory for Radiobiology and Molecular Genetics, Vinča Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, Mike Petrovića Alasa 12-14, Vinča, 11351 Belgrade, Serbia
1 shared publication - Marko Buta
Surgical Oncology clinic, Institute for Oncology and Radiology of Serbia, Pasterova 14, Belgrade, 11000, Serbia
1 shared publication - Petar Radlovic
Institute of Oncology and Radiology of Serbia, Surgical Oncology Clinic, Pasterova 14, 11000, Belgrade, Serbia
1 shared publication
Latest Publications
- Open Access
- 8 June 2012
- Published by Springer Nature in BMC Cancer
- Vol. 12 (1) , 224
Unilateral follicular variant of papillary thyroid carcinoma with unique KRAS mutation in struma ovarii in bilateral ovarian teratoma: a rare case report
Struma ovarii (SO) is a rare form of ovarian mature teratoma in which thyroid tissue is the predominant element. Because of its rarity, the differential diagnosis between benign and malignant SO has not been clearly defined. It is believed that malignant transformation of SO has similar molecular features with and its prognosis corresponds to that of malignant tumors originating in the thyroid.
- 8 June 2012
- Published by Springer Nature in BMC Cancer
- Vol. 12 (1) , 224
Open AccessUnilateral follicular variant of papillary thyroid carcinoma with unique KRAS mutation in struma ovarii in bilateral ovarian teratoma: a rare case report
Struma ovarii (SO) is a rare form of ovarian mature teratoma in which thyroid tissue is the predominant element. Because of its rarity, the differential diagnosis between benign and malignant SO has not been clearly defined. It is believed that malignant transformation of SO has similar molecular features with and its prognosis corresponds to that of malignant tumors originating in the thyroid.